ATX 0.00% 6.7¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-21

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    too early for licensing deal (imo)
    good to pay attention to what else is going on coz ATX doesn’t operate in a vacuum. Several FAK inhibitors in development, the one from Verastem oncology looks the most advanced. They also tout theirs as “best in class”!!
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.7¢
Change
0.000(0.00%)
Mkt cap ! $18.19M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 13348 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 43311 2
View Market Depth
Last trade - 15.15pm 19/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.